Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Liraglutide changes gut bacteria and improves blood vessel relaxation in diabetic mice

Updated

Abstract

Liraglutide significantly improved endothelium-dependent relaxation in db/db mice with type 2 diabetes mellitus.

  • Endothelial dysfunction is linked to cardiovascular complications in type 2 diabetes mellitus.
  • Liraglutide treatment restored high glucose-induced impairment of nitric oxide signaling in human endothelial cells.
  • Diabetes was associated with reduced gut microbiome diversity and a decrease in short-chain fatty acid-producing bacteria.
  • Liraglutide treatment improved gut microbiota composition by restoring microbial diversity and increasing beneficial genera.
  • Low-dose butyrate enhanced nitric oxide production in endothelial cells, suggesting a potential microbiome-related mechanism.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of Competing Interest None.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free